Pharma Journalist -

Softbox announces that it is launching its MAX range at the next IQPC Annual Cold Chain Global Forum (24-27 September) in Philadelphia. Softbox’s MAX range is a new addition to the…
Read More...

Gilead Sciences and Galapagos announced that the randomized, placebo-controlled Phase 2 TORTUGA study of filgotinib, an investigational, selective JAK1 inhibitor, achieved its primary…
Read More...

LEO Pharma and Bayer announced the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States.…
Read More...

Novartis announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo…
Read More...

NHS patients to benefit from Europe’s first full access deal on breakthrough CAR-T therapy. NHS England chief executive Simon Stevens has announced today that children and young…
Read More...

DZS Clinical Services, which provides clinical development and data analytic services for global pharmaceutical, biotech and medical device companies, announced that it has been…
Read More...

WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate) for metastatic colorectal cancer from the National Medical…
Read More...

Atara Biotherapeutics announced that it has entered into a strategic collaboration with Moffitt Cancer Center to develop multi‑targeted chimeric antigen receptor T-cell (CAR T)…
Read More...

Thrombolytic Science, LLC (TSI) announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of low-dose tissue…
Read More...

ADMA Biologics, a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty plasma-based biologics for the prevention and treatment of…
Read More...